Literature DB >> 33671444

Binding of Amyloid β(1-42)-Calmodulin Complexes to Plasma Membrane Lipid Rafts in Cerebellar Granule Neurons Alters Resting Cytosolic Calcium Homeostasis.

Joana Poejo1, Jairo Salazar1,2, Ana M Mata1,3, Carlos Gutierrez-Merino1,3.   

Abstract

Lipid rafts are a primary target in studies of amyloid β (Aβ) cytotoxicity in neurons. Exogenous Aβ peptides bind to lipid rafts, which in turn play a key role in Aβ uptake, leading to the formation of neurotoxic intracellular Aβ aggregates. On the other hand, dysregulation of intracellular calcium homeostasis in neurons has been observed in Alzheimer's disease (AD). In a previous work, we showed that Aβ(1-42), the prevalent Aβ peptide found in the amyloid plaques of AD patients, binds with high affinity to purified calmodulin (CaM), with a dissociation constant ≈1 nM. In this work, to experimentally assess the Aβ(1-42) binding capacity to intracellular CaM, we used primary cultures of mature cerebellar granule neurons (CGN) as a neuronal model. Our results showed a large complexation of submicromolar concentrations of Aβ(1-42) dimers by CaM in CGN, up to 120 ± 13 picomoles of Aβ(1-42) /2.5 × 106 cells. Using fluorescence microscopy imaging, we showed an extensive co-localization of CaM and Aβ(1-42) in lipid rafts in CGN stained with up to 100 picomoles of Aβ(1-42)-HiLyteTM-Fluor555 monomers. Intracellular Aβ(1-42) concentration in this range was achieved by 2 h incubation of CGN with 2 μM Aβ(1-42), and this treatment lowered the resting cytosolic calcium of mature CGN in partially depolarizing 25 mM potassium medium. We conclude that the primary cause of the resting cytosolic calcium decrease is the inhibition of L-type calcium channels of CGN by Aβ(1-42) dimers, whose activity is inhibited by CaM:Aβ(1-42) complexes bound to lipid rafts.

Entities:  

Keywords:  L-type calcium channels; amyloid β(1–42); calmodulin; cerebellar granule neurons; cytosolic calcium homeostasis; lipid rafts

Mesh:

Substances:

Year:  2021        PMID: 33671444      PMCID: PMC7923178          DOI: 10.3390/ijms22041984

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  74 in total

1.  Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo.

Authors:  Dominic M Walsh; Igor Klyubin; Julia V Fadeeva; William K Cullen; Roger Anwyl; Michael S Wolfe; Michael J Rowan; Dennis J Selkoe
Journal:  Nature       Date:  2002-04-04       Impact factor: 49.962

2.  Spectrofluorimetric analysis of the interaction of amyloid peptides with neuronal nitric oxide synthase: implications in Alzheimer's disease.

Authors:  Eden R Padayachee; Chris G Whiteley
Journal:  Biochim Biophys Acta       Date:  2011-09-10

Review 3.  Calcium signaling and amyloid toxicity in Alzheimer disease.

Authors:  Angelo Demuro; Ian Parker; Grace E Stutzmann
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

4.  Calmodulin is the Ca2+ sensor for Ca2+ -dependent inactivation of L-type calcium channels.

Authors:  B Z Peterson; C D DeMaria; J P Adelman; D T Yue
Journal:  Neuron       Date:  1999-03       Impact factor: 17.173

5.  Alteration of cytosolic free calcium homeostasis by SIN-1: high sensitivity of L-type Ca2+ channels to extracellular oxidative/nitrosative stress in cerebellar granule cells.

Authors:  Yolanda Gutiérrez-Martín; Francisco Javier Martín-Romero; Fernando Henao; Carlos Gutiérrez-Merino
Journal:  J Neurochem       Date:  2005-02       Impact factor: 5.372

6.  Acceleration of amyloid fibril formation by specific binding of Abeta-(1-40) peptide to ganglioside-containing membrane vesicles.

Authors:  L P Choo-Smith; W Garzon-Rodriguez; C G Glabe; W K Surewicz
Journal:  J Biol Chem       Date:  1997-09-12       Impact factor: 5.157

7.  Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice.

Authors:  Lauren M Billings; Salvatore Oddo; Kim N Green; James L McGaugh; Frank M LaFerla
Journal:  Neuron       Date:  2005-03-03       Impact factor: 17.173

8.  Dimeric amyloid beta protein rapidly accumulates in lipid rafts followed by apolipoprotein E and phosphorylated tau accumulation in the Tg2576 mouse model of Alzheimer's disease.

Authors:  Takeshi Kawarabayashi; Mikio Shoji; Linda H Younkin; Lin Wen-Lang; Dennis W Dickson; Tetsuro Murakami; Etsuro Matsubara; Koji Abe; Karen Hsiao Ashe; Steven G Younkin
Journal:  J Neurosci       Date:  2004-04-14       Impact factor: 6.167

9.  Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide.

Authors:  Xiaoyan Hu; Scott L Crick; Guojun Bu; Carl Frieden; Rohit V Pappu; Jin-Moo Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-12       Impact factor: 11.205

Review 10.  Brain membrane cholesterol domains, aging and amyloid beta-peptides.

Authors:  W Gibson Wood; Friedhelm Schroeder; Urule Igbavboa; Nicolai A Avdulov; Svetlana V Chochina
Journal:  Neurobiol Aging       Date:  2002 Sep-Oct       Impact factor: 4.673

View more
  3 in total

1.  Design and Experimental Evaluation of a Peptide Antagonist against Amyloid β(1-42) Interactions with Calmodulin and Calbindin-D28k.

Authors:  Jairo Salazar; Joana Poejo; Ana M Mata; Alejandro K Samhan-Arias; Carlos Gutierrez-Merino
Journal:  Int J Mol Sci       Date:  2022-02-18       Impact factor: 5.923

2.  Binding mode analysis of ABCA7 for the prediction of novel Alzheimer's disease therapeutics.

Authors:  Vigneshwaran Namasivayam; Katja Stefan; Jens Pahnke; Sven Marcel Stefan
Journal:  Comput Struct Biotechnol J       Date:  2021-11-27       Impact factor: 7.271

Review 3.  The Relevance of Amyloid β-Calmodulin Complexation in Neurons and Brain Degeneration in Alzheimer's Disease.

Authors:  Joana Poejo; Jairo Salazar; Ana M Mata; Carlos Gutierrez-Merino
Journal:  Int J Mol Sci       Date:  2021-05-07       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.